Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
9Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
bioAffinity Technologies, Inc. (BIAF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
14Total relationships
2Distinct source URLs
9High confidence
0.814Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from MYGN graph: Reciprocal relationship from BIAF graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from BIAF graph: Reciprocal relationship from MYGN g…
bioAffinity Technologies, Inc. Customers
Ticker
Name
Confidence
Evidence
CONTRACT-RESEARCH-ORGANIZATIONS
CONTRACT-RESEARCH-ORGANIZATIONS
90%
The Company's other customer types include contract research organizations ("CRO's), hospitals, and independent laboratories.
HOSPITALS
HOSPITALS
90%
The Company's other customer types include contract research organizations ("CRO's), hospitals, and independent laboratories.
INDEPENDENT-LABORATORIES
INDEPENDENT-LABORATORIES
90%
The Company's other customer types include contract research organizations ("CRO's), hospitals, and independent laboratories.
GOVERNMENTAL-PAYORS
GOVERNMENTAL-PAYORS
85%
Furthermore, in addition to its contracts with patients, the Company separately contracts with third-party payors (insurance companies and governmental payors), who are typically responsible for all …
INSURANCE-COMPANIES
INSURANCE-COMPANIES
85%
Furthermore, in addition to its contracts with patients, the Company separately contracts with third-party payors (insurance companies and governmental payors), who are typically responsible for all …
Reciprocal relationship from MYGN graph: Reciprocal relationship from BIAF graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from BIAF graph: Reciprocal relationship from MYGN g…
ddition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent’s claims narrowly, or refuse to stop the o…
EMERGING-GROWTH-COMPANY
EMERGING-GROWTH-COMPANY
62%
d process, which considers historical denial and collection experience and other factors (including the period of time that the receivables have been outstanding), to estimate contractual allowances …
THERAPEUTICS-LLC
THERAPEUTICS-LLC
62%
the foreseeable future. As a result, the Company had an accumulated deficit of $ 68.6 million at December 31, 2025. The Company’s cash and cash equivalents at December 31, 2025, were approximately $ …
bioAffinity Technologies, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
BIAF-DEBT-8187
Warrants outstanding: 2317607
90%
xbrl warrant detail from xbrl 2026-03-31.
BIAF-DEBT-8188
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2022-12-31.
BIAF-DEBT
Debt stack $1.2M
90%
Market cache reports total debt of $1.2M.
bioAffinity Technologies, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for bioAffinity Technologies, Inc..
bioAffinity Technologies, Inc. Ownership
Holder
Name
Confidence
Evidence
BIAF-OWNER-BARCLAYS-PLC
BARCLAYS PLC
90%
13F overlay lists BARCLAYS PLC as top holder; 1 tracked holders.
bioAffinity Technologies, Inc. Extended Supply Chain Network
